• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Eastman Chemical Company filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    5/5/25 5:08:35 PM ET
    $EMN
    Major Chemicals
    Industrials
    Get the next $EMN alert in real time by email
    emn-20250501
    0000915389false00009153892025-05-012025-05-010000915389us-gaap:CommonStockMember2025-05-012025-05-010000915389emn:A1.875notesdueNovember2026Member2025-05-012025-05-01

    Eastman_Black_300dpi.jpg

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    WASHINGTON, DC 20549

    FORM 8-K
    CURRENT REPORT
    Pursuant to Section 13 or 15 (d) of The Securities Exchange Act of 1934

    Date of report (Date of earliest event reported):
    May 1, 2025

    EASTMAN CHEMICAL COMPANY
    (Exact Name of Registrant as Specified in Its Charter)
    Delaware 1-12626 62-1539359
    (State or Other Jurisdiction
    of Incorporation)
     (Commission File Number) (IRS Employer
    Identification No.)
    200 South Wilcox Drive 
    KingsportTennessee37662
    (Address of Principal Executive Offices)(Zip Code)
    (423) 229-2000
    (Registrant’s Telephone Number, Including Area Code)
      
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
     ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
        
     ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
        
     ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
        
     ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:
    Title of each class Trading Symbol(s)Name of each exchange on which registered
    Common Stock, par value $0.01 per share EMNNew York Stock Exchange
    1.875% Notes Due 2026EMN26New York Stock Exchange

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

    Emerging growth company ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐




    Item 5.07 Submission of Matters to a Vote of Security Holders

    The 2025 Annual Meeting of the Stockholders (the “Annual Meeting”) of Eastman Chemical Company (the "Company") was held on May 1, 2025. There were 115,459,908 shares of common stock outstanding and entitled to be voted, and of those shares 102,814,068 were represented virtually or by proxy, at the Annual Meeting.

    Four items of business were considered by stockholders at the Annual Meeting:

    •The election of ten directors to serve until the Annual Meeting of Stockholders in 2026 and until their successors are duly elected and qualified;
    •Ratification of the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2025;
    •An advisory vote on executive compensation (the “say-on-pay” vote) as disclosed in the 2025 Annual Meeting Proxy Statement (the “Proxy Statement”); and
    •An advisory vote on stockholder proposal regarding an independent Board Chair as disclosed in the Proxy Statement.

    1.The results of the voting on the election of directors were as follows:
    Nominee
    Votes For
    Votes Against
    Abstentions
    Broker Non-Votes
    Humberto P. Alfonso
    89,355,822
    5,002,946
    107,726
    8,347,574
    Brett D. Begemann
    88,932,400
    5,433,509
    100,585
    8,347,574
    Eric L. Butler
    93,949,411
    410,523
    106,565
    8,347,569
    Mark J. Costa
    87,034,425
    7,319,177
    112,892
    8,347,574
    Linnie M. Haynesworth
    93,800,245
    566,606
    99,647
    8,347,570
    Julie F. Holder
    84,412,239
    9,954,090
    100,166
    8,347,573
    Renée J. Hornbaker
    88,518,211
    5,795,214
    153,066
    8,347,577
    Kim Ann Mink
    93,785,505
    585,151
    95,842
    8,347,570
    James J. O'Brien
    91,445,878
    2,920,624
    99,994
    8,347,572
    Donald W. Slager
    94,072,309
    291,963
    102,225
    8,347,571

    Accordingly, each of the ten nominees received a majority of votes cast in favor of that director's election and was elected.


    2.The results of the voting on the ratification of the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the Company for 2025 were as follows:
    Votes For
    Votes Against
    Abstentions
    Broker Non-Votes
    97,392,559
    5,299,223
    122,286
    0

    Accordingly, a majority of votes cast on the ratification of the appointment of the independent registered public accounting firm were in favor of the proposal and the appointment of PricewaterhouseCoopers LLP was ratified.











    3.The results of the voting on the advisory "say-on-pay" vote were as follows:
    Votes For
    Votes Against
    Abstentions
    Broker Non-Votes
    87,798,103
    6,180,978
    487,406
    8,347,581

    Accordingly, a majority of votes cast in the advisory "say-on-pay" vote were "for" approval of the executive compensation as disclosed in the Proxy Statement.


    4.The results of the voting on the advisory stockholder proposal regarding an independent Board Chair were as follows:

    Votes For
    Votes Against
    Abstentions
    Broker Non-Votes
    28,284,498
    65,926,938
    255,052
    8,347,580

    Accordingly, a majority of votes cast on this stockholder proposal were not in favor of the advisory proposal and the proposal was not adopted.


    SIGNATURES


    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
     
      
    Eastman Chemical Company 
     
     By:/s/ Iké G. Adeyemi
            Iké G. Adeyemi
          Senior Vice President, Chief Legal Officer and
          Corporate Secretary
          Date: May 5, 2025
     


    Get the next $EMN alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $EMN

    DatePrice TargetRatingAnalyst
    4/28/2025$76.00Overweight → Neutral
    Analyst
    4/9/2025$91.00Sector Perform → Outperform
    RBC Capital Mkts
    4/4/2025$101.00Neutral → Buy
    Citigroup
    4/3/2025$105.00Neutral → Outperform
    Mizuho
    1/14/2025$115.00 → $109.00Neutral → Buy
    BofA Securities
    12/18/2024$118.00 → $104.00Buy → Neutral
    Citigroup
    11/26/2024$110.00 → $125.00Equal Weight → Overweight
    Wells Fargo
    10/16/2024$114.00 → $119.00Buy → Neutral
    BofA Securities
    More analyst ratings